Last updated: 29 May 2024 at 4:42pm EST

Matthew Strobeck Net Worth




The estimated Net Worth of Matthew Strobeck is at least $115 Million dollars as of 21 May 2024. Matthew Strobeck owns over 347,840 units of QuidelOrtho stock worth over $115,303,923 and over the last 12 years he sold QDEL stock worth over $0. In addition, he makes $184,917 as Independent Director at QuidelOrtho.

Matthew Strobeck QDEL stock SEC Form 4 insiders trading

Matthew has made over 22 trades of the QuidelOrtho stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 347,840 units of QDEL stock worth $15,600,624 on 21 May 2024.

The largest trade he's ever made was buying 2,669,562 units of QuidelOrtho stock on 21 November 2022 worth over $3,069,996. On average, Matthew trades about 80,253 units every 60 days since 2013. As of 21 May 2024 he still owns at least 2,570,879 units of QuidelOrtho stock.

You can see the complete history of Matthew Strobeck stock trades at the bottom of the page.





Matthew Strobeck biography

Dr. Matthew W. Strobeck is Independent Director of the Company. Dr. Strobeck is currently the Managing Partner of Birchview Capital. Dr. Strobeck was a Partner and Member of the Management Committee and Advisory Board of Westfield Capital Management from 2008 until 2011, having served as a member of the investment team, specializing in healthcare and life sciences, from May 2003 to June 2008. Dr. Strobeck currently serves on the Boards of Accelerate Diagnostics, a medical diagnostics company; Tepha Inc., a medical device company; Biodesix, a private diagnostic company; and Monteris Medical, a medical device company. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, a S.M. from the Harvard University/MIT Health Sciences Technology Program, and an S.M. from the MIT Sloan School of Management.

What is the salary of Matthew Strobeck?

As the Independent Director of QuidelOrtho, the total compensation of Matthew Strobeck at QuidelOrtho is $184,917. There are 17 executives at QuidelOrtho getting paid more, with Douglas Bryant having the highest compensation of $4,168,770.



How old is Matthew Strobeck?

Matthew Strobeck is 47, he's been the Independent Director of QuidelOrtho since 2018. There are 26 older and 1 younger executives at QuidelOrtho. The oldest executive at QuidelOrtho Corporation is Mary Polan, 76, who is the Independent Director.

What's Matthew Strobeck's mailing address?

Matthew's mailing address filed with the SEC is 9975 SUMMERS RIDGE ROAD, , SAN DIEGO, CA, 92121.

Insiders trading at QuidelOrtho

Over the last 21 years, insiders at QuidelOrtho have traded over $509,235,797 worth of QuidelOrtho stock and bought 304,015 units worth $10,385,234 . The most active insiders traders include Jack W Schuler, Matthew Strobeck, and Group Inc.Carlyle Holdings .... On average, QuidelOrtho executives and independent directors trade stock every 16 days with the average trade being worth of $1,246,606. The most recent stock trade was executed by Group Inc.Carlyle Holdings ... on 9 August 2024, trading 74,134 units of QDEL stock currently worth $3,078,785.



What does QuidelOrtho do?

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.



Complete history of Matthew Strobeck stock trades at Accelerate Diagnostics Inc, QuidelOrtho, and Biodesix Inc

Insider
Trans.
Transaction
Total value
Matthew Strobeck
Option $546,109
21 May 2024
Matthew Strobeck
Buy $3,069,996
21 Nov 2022
Matthew Strobeck
Buy $1,999,999
7 Apr 2022
Matthew Strobeck
Option $33,874
31 Mar 2022
Matthew Strobeck
Buy $642,930
30 Dec 2021
Matthew Strobeck
Option $400,218
7 Dec 2020
Matthew Strobeck
Buy $1,499,994
18 Jun 2020
Matthew Strobeck
Director
Buy $134,000
23 Jan 2024
Matthew Strobeck
Director
Buy $71,100
18 Mar 2020
Matthew Strobeck
Director
Buy $152,000
9 Jan 2017
Matthew Strobeck
Director
Buy $230,400
9 Feb 2016
Matthew Strobeck
Director
Buy $230,400
9 Feb 2016
Matthew Strobeck
Director
Buy $1,499,995
15 Dec 2015
Matthew Strobeck
Director
Buy $1,499,995
15 Dec 2015
Matthew Strobeck
Director
Buy $44,080
19 Mar 2015
Matthew Strobeck
Director
Buy $334,000
5 Aug 2014
Matthew Strobeck
Option $162,465
18 May 2022
Matthew Strobeck
Option $124,738
12 May 2021
Matthew Strobeck
Buy $1,278,739
2 Sep 2020
Matthew Strobeck
Option $390,033
14 May 2020
Matthew Strobeck
Option $94,876
14 May 2019
Matthew Strobeck
Option $6,498
15 May 2018


QuidelOrtho executives and stock owners

QuidelOrtho executives and other stock owners filed with the SEC include: